| PACKAGING TYPE: | 10x10 Blister (10 Strips In 1 Box) |
| COMPOSITION: | Linagliptin(2.5mg) & Metformin(500mg) Tablet |
| FORMULATION: | Tablet |
| Description: | METFIG-L 2.5/500 Tablet is a combination antidiabetic medication containing Linagliptin 2.5mg and Metformin 500mg. It is widely used for the effective management of type 2 diabetes mellitus, especially in patients requiring combination therapy with a lower dose of Metformin. Linagliptin, a DPP-4 inhibitor, increases incretin hormone levels to enhance insulin secretion and suppress glucagon release, while Metformin reduces hepatic glucose production and improves insulin sensitivity. This balanced formulation helps achieve better glycemic control with improved tolerability. |
| Side Effects: | Common side effects may include: Nausea Diarrhea Abdominal discomfort Headache Metallic taste Mild hypoglycemia (rare) Note: Side effects are generally mild and decrease over time. |
| How to Use: | Take METFIG-L 2.5/500 Tablet as prescribed by a healthcare professional Usually taken once or twice daily with meals Swallow whole with water; do not crush or chew Take at the same time each day for consistency Follow proper diet and exercise routine |
| Precaution: | Monitor blood glucose levels regularly Use cautiously in patients with kidney or liver disorders Avoid excessive alcohol consumption Not recommended in severe renal impairment Inform your doctor about all medications being taken Use during pregnancy and breastfeeding only if advised |
| Product Benefits: | Dual-action formula for effective blood sugar control Helps reduce fasting and post-meal glucose levels Lower dose of Metformin improves gastrointestinal tolerability Enhances insulin secretion and sensitivity Low risk of hypoglycemia when used alone |
Frequently Asked Questions
It is used for managing type 2 diabetes, particularly in patients requiring combination therapy with a lower dose of Metformin.
Yes, the lower Metformin content helps reduce gastrointestinal side effects.
Yes, it is suitable for long-term diabetes management under medical supervision.













